Abbott

YTD

ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

CEO

Robert B. Ford

CEORobert B. Ford

Employees

115,000

Employees115,000

Headquarters

Abbott Park, Illinois

HeadquartersAbbott Park, Illinois

Founded

1888

Founded1888

Employees

115,000

Employees115,000

ABT Key Statistics

Market cap

151.83B

Market cap151.83B

Price-Earnings ratio

24.39

Price-Earnings ratio24.39

Dividend yield

2.79%

Dividend yield2.79%

Average volume

13.80M

Average volume13.80M

High today

$88.31

High today$88.31

Low today

$86.16

Low today$86.16

Open price

$87.31

Open price$87.31

Volume

17.19M

Volume17.19M

52 Week high

$139.06

52 Week high$139.06

52 Week low

$86.16

52 Week low$86.16

Stock Snapshot

Abbott(ABT) stock is priced at $87.20, giving the company a market capitalization of 151.83B. It carries a P/E multiple of 24.39 and pays a dividend yield of 2.8%.

As of 2026-05-06, Abbott(ABT) stock has fluctuated between $86.16 and $88.31. The current price stands at $87.20, placing the stock +1.2% above today's low and -1.3% off the high.

Abbott(ABT) shares are trading with a volume of 17.19M, against a daily average of 13.8M.

In the last year, Abbott(ABT) shares hit a 52-week high of $139.06 and a 52-week low of $86.16.

ABT News

Nasdaq 3d

This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy?

Abbott Laboratories (NYSE: ABT) is offering income investors a rare setup: a yield is approaching 3% while the business continues to grow. The stock isn't a scr...

TipRanks 5d

Abbott removed from US Conviction List at Goldman Sachs

Goldman Sachs analysts removed Abbott (ABT) from the firm’s US Conviction List as part of its monthly update. Unlock hedge fund-level data and powerful investi...

Simply Wall St 7d

Abbott’s Ultreon 3.0 AI Imaging Clearance And What It Means For Valuation

Abbott Laboratories (NYSE:ABT) received U.S. FDA clearance and CE Mark for its AI powered Ultreon 3.0 Software. Ultreon 3.0 is a next generation coronary imagi...

Analyst ratings

77%

of 31 ratings

Buy

77.4%

Hold

22.6%

Sell

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.